Abstract

Background & Objectives: Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis. All over the world TB is one of the leading causes of mortality and morbidity. Interferon-gamma (IFN-γ), at the site of MTB infection, activates macrophages to kill intracellular mycobacteria. CD8+ T cells kill the cells infected by viruses and other intracellular microbes. Diagnostic significance of IFN-γ has been reviewed in latent and active TB. Aim of this study was to determine association between IFN-γ and CD8+ T-cells in the blood of pulmonary TB-patients. Methods: Study consisted of 54-TB-patients and 38 healthy subjects. Level of IFN-γ was determined by ELISA and percentage of CD8+ T-cells by flow cytometry. Results: Level of IFN-γ and percentage of CD8+ T-lymphocytes were high in the blood of TB patients compared to control. Conclusion: TB patients had high level of IFN-γ compared to healthy controls. IFN-γ and CD8+ T cells were negatively correlated with duration of treatment of tuberculosis. There was no difference in percentage of CD8+ T cells in TB patients after 3 months of chemotherapy compared to controls.

Keywords: Interferon gamma · Tuberculosis · CD8+ T lymphocytes

References

  1. 1.Ducati R, Ruffino-Netto A, Basso L, Santos D. The resumptionofconsumption. Areviewontuberculosis. Mem Inst Oswaldo Cruz, Rio de Janeiro, 2006; 101(7): 697-714.
  2. 2.WHO media center (http://www.who.int/ mediacentre/factsheets/fs104/en/).
  3. 3.WHO report 2008, Global tuberculosis control; TB publications, Annex 1- profiles of high-burden countries, Pakistan PDF. pp. 133.
  4. 4.Aamer I, Sakhawat A, Wajid A, Wiqar MA. Latest Pattern of Multi-Drug Resistant Tuberculosis in Pakistan.InfectiousDiseasesJournalofPakistan2008; 17(01):14-17
  5. 5.Brook,GeoF.;Carroll,KarenC.;Butel,JanetS.;Morse, Stephen A. Jawet’s Medical Microbiology (24th ed.) McGrawHill,LANGESeries.2007.Chapter24,pp.320- 329
  6. 6.Kumar Vinay; Abbas Abul K.; Fausto Nelson; Mitchell, RichardN.RobbinsBasicPathology(8thEd.).Saunders Elsevier. 2007. pp. 516-522.
  7. 7.PalominoJC,LeaoSC.Tuberculosis.FromBasicScience topatientcare.1stedn. www.Tuberculosistextbook. com/tuberculosis 2007.pdf
  8. 8.Leinhardt C, Azzurri A, Amedei A, Fielding K, Sillah J, SowOYetal.ActivetuberculosisinAfricaisassociated with reduced Th1 and increased Th2 activity in vivo. Eur J Immunol. 2002; 32:1605-13.
  9. 9.Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG,OrmeIM.Disseminatedtuberculosisininterferon gamma genedisrupted mice. J Exp Med. 1993; 178:2243-7.
  10. 10.Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon-γ in resistance to Mycobacterium tuberculosis infection. J Exp Med. 1993; 178:2249-54.
  11. 11.MosmannTR,CoffmanRL.Th1andTh2cells:different pattern of lymphokine secretion lead to different functional properties. Annul Rev Immunol 1989; 7: 145-173.
  12. 12.Schluns KS, and L Lefrancois. Cytokine control of memory lymphocyte development and survival. Original Article 20  MAJMAAH JOURNAL OF HEALTH SCIENCE, Vol 2, Issue 1, 2014 Interferon-gamma and T cells in Tuberculosis, Afzal N et al Nature Reviews Immunology 2003; 3:269-279.
  13. 13.BhatnagarR,MalaviyaAN,NarayananS,RajgopalanP, KumarR.Spectrumofimmuneresponseabnormalities in different forms of tuberculosis. The American ReviewofRespiratoryDisease.1977;115(2):207-212.
  14. 14.Deveci F, Handan H. Lymphocyte subpopulation in pulmonary tuberculosis patients. Mediators of inflammation 2006; 1-6.
  15. 15.Jiang J, Shi HZ. Diagnostic value of interferon- γ in tuberculosis pleurisy: a meta-analysis. Chest 2007; 131: 1133-1141.
  16. 16.KimYC,ParkKO,BomHS,LimSC,ParkHK,NaHJ,etal. Combining ADA, protein and IFN-gamma best allows discrimination between tuberculosis and malignant pleural effusion. Korean J Intern Med. 1997; 12:225-
  17. 17.Hussain S, Afzal N, Javaid K, Ikram-Ullah M, Ahmad T and Adhami SZ. Level of interferon-gamma in the bloodoftuberculosispatients.Iran.J.Immunol.2010; 7(4):240-246
  18. 18.AfzalN,JavaidK,Saleem-u-Zaman,MumtazA,Hussain S, Tahir R, Ullah I et al. Percentage of CD4+ and CD8+ T-lymphocytes in the blood of tuberculosis patients. J Ayub Med Coll Abottabad. 2010;22(4):182-186
  19. 19.Zohreh P, Fosul FS, Farzad O, Ahmad G, Kiani A and Zahra SD. Immunophenotypic characterization of peripheral blood T-lymphocytes and their subpopulations in tuberculosis patients before and after treatments. Iranian Journal of Allergy, Asthma And Immunology 2005; 4(1): 23-26.
  20. 20.Gariby-Escobar. Immunophenotyping analysis of peripheral T and B lyphocytes in patients with chronic pulmonary tuberculosis. Int Cong on Infct Dis Abs, Pos, Pres 2008; 05. 1343.
  21. 21.Behar S. Antigen-specific CD8+ T cells and protective immunity to tuberculosis. Adv Exp Med Biol. 2013;783:141-63
  22. 22.FlynnJL,ChanJ.Tuberculosis:latencyandreactivation. Infect Immun 2001; 69: 4195–201.
  23. 23.Kaufmann SH, McMichael AJ. Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis. Nat Med 2005; 11: S33–44.
  24. 24.Mori T, Sakatani M, Yamagishi F, Takashima T, Kawabe Y, Nagao K et al. Specific detection of tuberculosis infection: an interferon-γ-based assay using new antigens.AmJRespirCritCareMed.2004;170:59–64.
  25. 25.Stenger S, Mazzaccaro, Uyemura, Cho, S, Barnes, Rosat, et al. Differential Effects of Cytolytic T Cell Subsets on Intracellular Infection. Science 1997; 276: 1684–1687.
  26. 26.Stenger, S., Hanson, D. A., Teitlebaum, R., Dewan, P., Niazi, K. R., Froelich, et al. An Antimicrobial Activity of Cytolytic T Cells Mediated by Granulysin. Science 1998; 282: 121–125.
  27. 27.BeharSM,DascherCC,GrusbyMJ,WangCR&Brenner MB. Susceptibility of Mice Deficient in CD1D or TAP1 to Infection with Mycobacterium tuberculosis. J. Exp. Med 1999; 189: 1973–1980.
  28. 28.Flynn JL, Goldstein MM, Triebold KJ, Koller B & Bloom BR.MajorhistocompatibilitycomplexclassI-restricted T cells are required for resistance to Mycobacterium tuberculosisinfection.Proc.Natl.Acad.Sci.USA1992; 89: 12013–12017.
  29. 29.Cho S, Mehra V, Thoma-Uszynski S, Stenger S, Serbina N,etal.AntimicrobialactivityofMHCclassI-restricted CD8+ T cells in human tuberculosis. Proc Natl Acad Sci U S A 2000; 97: 12210–5.
  30. 30.Claudia Carranza, Esmeralda Jua´rez, Martha Torres, Jerrold J. Ellner, Eduardo Sada et al. Mycobacterium tuberculosis Growth Control by Lung Macrophages and CD8 Cells from Patient Contacts. Am J Respir Crit Care Med 2006; 173: 238–245.
  31. 31.Gariby-Escobar. Immunophenotyping analysis of peripheral T and B lyphocytes in patients with chronic pulmonary tuberculosis. Int Cong on Infct Dis Abs, Pos, Pres 2008; 05. 1343.
  32. 32.Rozot V, Vigano S, Stalder JM, Idrizi E, Day CL, Perreau M et al. Mycobacterium tuberculosis-specific CD8+ T cells are functionally and phenotypically different between latent infection and active disease. EJI 2013; 43: 1568-1577.
  33. 33.Lukary T, Brook F, Alm´erio M, Krisztina E, Lee R, S´ergio A. Levels of Interferon-Gamma Increase after Treatment for Latent Tuberculosis Infection in a High-Transmission Setting. Pul Med 2012; (6): doi:10.1155/2012/757152 doi:10.1155/2012/757152
  34. 34.http://www.who.int/tb/features_archive/igra_ policy24oct/en/. New WHO Recommendations on use of commercial TB Interferon-Gamma Release Assays (IGRAs) in lowand middle-income countries. October 24, 2011
  35. 35.Caccamo N, Guggino G, Meraviglia S, Gelsomino G, Di CarloP,etal.AnalysisofMycobacteriumtuberculosis- SpecificCD8T-CellsinPatientswithActiveTuberculosis and in Individuals with Latent Infection. PLoS ONE 2009; 4(5): e5528. Original Article
Majmaah Journal of Health Sciences · eISSN 1658-8223 · Majmaah University · open access